Welcome to our community

Be apart of something great, join today!

Register Log in

U.S. Budget Negotiations

  • Thread starter Thread starter nycfan
  • Start date Start date
  • Replies: 1K
  • Views: 28K
  • Politics 
heelinhell said:
So Vance broke the tie ?

I assume it was pre-arranged to allow Collins to vote no because she is up for re-election next year. She would not have voted no without permission.

Murkowski could vote yes because she is not up for re-election until 2028
Click to expand...
Exactly.

Collins votes as a “moderate” when the GOP doesn’t need her vote.

And, Maine voters are stupid enough to vote for her AGAIN.

Ask, “Who was the last Democrat elected to the US Senate from Maine?”

It was George Mitchell.

In 1988.
 
Last edited:

President Donald Trump’s “big beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide care to them.

The Senate on Tuesday voted 51-50 to pass the spending measure after a marathon overnight voting session on amendments. But the bill will face another major test in the House, where Republicans have a razor-thin majority and some members have already raised objections to the legislation.




Recent changes to the bill would cut roughly $1.1 trillion in health-care spending over the next decade, according to new estimates from the nonpartisan Congressional Budget Office.

More than $1 trillion of those cuts would come from Medicaid, a joint federal and state health insurance program for disabled and low-income Americans, according to the CBO. The funding cuts go beyond insurance coverage: The loss of that funding could gut many rural hospitals that disproportionately rely on federal spending.

The CBO estimates that the current version of the bill would result in 11.8 million people losing health insurance by 2034, with the majority of those people losing Medicaid coverage.

But the implications could be even bigger. Trump’s bill combined with separate policy changes could result in an estimated 17 million people losing health insurance, said Robin Rudowitz, director of the program on Medicaid and the uninsured at health policy research organization KFF.

She said those other changes include new regulations that would dramatically limit access to Affordable Care Act Marketplace coverage and expiring enhanced ACA tax credits.




“If all of this comes to pass, it would represent the biggest roll back of health insurance coverage ever due to federal policy changes,” Cynthia Cox, KFF’s director of the program on the ACA, said in an analysis published Tuesday.
 
Senate Republicans handed a win to drugmakers after they added back a provision into the bill that would exempt more medicines from the Inflation Reduction Act’s Medicare drug price negotiations.

Under the bill, medicines used to treat multiple rare diseases will be exempt from those price talks between Medicare and manufacturers. The Senate initially left out that provision, called the ORPHAN Cures Act, in its first draft of the bill last month.

The pharmaceutical industry argues that excluding those drugs from the negotiations will encourage more investments in treatments for rare conditions. Currently, only drugs that treat a single rare disease or condition can be exempted from price talks.

“The ORPHAN Cures Act will enable more options for Americans living with rare disease,” the trade group Biotechnology Innovation Organization wrote Wednesday in a post on X. The group also said only 5% of rare diseases have an approved treatment, while the economic toll of rare conditions in the U.S. surpassed $997 billion in 2019.

But on Tuesday, drug pricing group Patients For Affordable Drugs Now called on the House to remove the ORPHAN Cures Act from the bill and allow Medicare drug price negotiations to deliver more savings to patients.

The decision to include it in the legislation “moves us in the wrong direction, undermining hard-fought progress to lower drug prices,” Merith Basey, executive director of the group, said in a statement.
 
You must log in or register to reply here.
Back
Top